ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,360Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1001

$1.81M Total Retail Price of All Prescriptions

Rank: 5 out of 1001

307 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 307 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 3,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

79% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$246 was the average price of a prescription from this provider, compared to $112 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EXELON 611 573 1 87
VIMPAT 453 147 2 238
NUEDEXTA 385 196 10 3 275
GRALISE 370 169 10 4 280
NAMENDA 285 263 5 31
CYMBALTA 271 164 6 73
LEXAPRO 238 156 7 250
PENNSAID 206 80 10 8 292
ESCITALOPRAM OXALATE 205 150 9 110
VIIBRYD 185 73 10 339
CARISOPRODOL 165 80 R 11 195
LAMICTAL XR 164 65 10 12 411
QUETIAPINE FUMARATE 153 63 13 76
CELEBREX 143 44 14 78
TREXIMET 137 21 10 15 426
NAPRELAN 136 63 10 16 429
SEROQUEL 106 43 17 191
LUNESTA 104 61 18 312
PEXEVA 95 79 10 19 481
OLANZAPINE 92 69 20 111
DEXILANT 89 24 21 116
PAROXETINE HCL 83 59 22 98
LIDODERM 80 46 23 108
PRISTIQ ER 75 42 24 337
BUPROPION XL 72 62 25 162
NEUPRO 72 51 10 25 441
LYRICA 72 35 25 117
GABAPENTIN 67 27 28 17
VENLAFAXINE HCL ER 66 36 29 197
SEROQUEL XR 64 19 30 247
RISPERIDONE 62 50 31 59
HORIZANT 58 36 10 32 543
PRAMIPEXOLE DIHYDROCHLORIDE 56 54 33 270
NUVIGIL 51 29 34 575
ABILIFY 51 16 34 99
LATUDA 50 16 36 581
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.